20-F 1 tmb-20201231x20f.htm 20-F Table
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone ...
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments | Oncology
Boston Scientific's Ion Stent Demonstrates Positive Outcomes in PERSEUS Trial | DAIC
PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration | SpringerLink
61904-5.fp.png "FINAL LONG-TERM FOLLOW-UP OF THE PLATINUM CHROMIUM TAXUS ELEMENT (ION) STENT: PERSEUS FIVE-YEAR RESULTS | Journal of the American College of Cardiology")
FINAL LONG-TERM FOLLOW-UP OF THE PLATINUM CHROMIUM TAXUS ELEMENT (ION) STENT: PERSEUS FIVE-YEAR RESULTS | Journal of the American College of Cardiology
MM - ASCO 2020: Hematologic Malignancies - Hematologic Malignancies - 2020 ASCO Annual Meeting - Oncology - Clinical Care Options
Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, E | CMAR
PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration | SpringerLink
A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS
Newly Diagnosed Myeloma in 2020 | American Society of Clinical Oncology Educational Book
Clinical Resources Now Available... - The Perseus Foundation | Facebook
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01 - ScienceDirect
Newton Biocapital I… | Newton Biocapital - Life Sciences Investments
ASH 2019: Thank you Daratumumab: The Era of Four Drug Upfront Therapy for Newly Diagnosed Patients Has Arrived
Progressive MS Patients Urged to Enroll in Phase 3 Trials of Tolebrutinib
EMN17 - European Myeloma Network
Perseus BV | LinkedIn
Slide 1 PERSEUS Primary Endpoint Dean Kereiakes ACC/i2 Late Breaking Trial Monday, March 15, 2010, 11:06 am TAXUS PERSEUS A Novel Platinum Chromium, Thin-Strut. - ppt download
PERSEUS:Exploratory paediatric study on the use and safety of EGCG in Down syndrome sufferers. - Clinical trials with volunteers - IMIM Institut Hospital del Mar d'Investigacions Mèdiques
Analysis of Two Trials Identified No Longitudinal Stent Deformation With Boston Scientific Stents | DAIC
Participate in clinical trials | Hospital da Luz Lisboa
ASH 2019: Thank you Daratumumab: The Era of Four Drug Upfront Therapy for Newly Diagnosed Patients Has Arrived
